title: Treatment of steroid resistant acute rejection after renal transplantation.
authors.affiliation: Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
authors.forename: C K
authors.initials: CK
authors.lastname: Oh
authors.forename: Y S
authors.initials: YS
authors.lastname: Kim
authors.forename: M S
authors.initials: MS
authors.lastname: Kim
authors.forename: S I
authors.initials: SI
authors.lastname: Kim
authors.forename: K
authors.initials: K
authors.lastname: Park
mesh_terms: D000082:Acetaminophen / Q000627:therapeutic use; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use; D004155:Diphenhydramine / Q000627:therapeutic use; D004351:Drug Resistance; D006084:Graft Rejection / Q000628:therapy*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000009:adverse effects / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D012008:Recurrence
chemical_list: D018712:Analgesics, Non-Narcotic; D000961:Antilymphocyte Serum; D006634:Histamine H1 Antagonists; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D000082:Acetaminophen; D016572:Cyclosporine; D004155:Diphenhydramine; D006854:Hydrocortisone; D008775:Methylprednisolone